HCA Healthcare, Inc.
HCA- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000860730
No open-market purchases or sales by HCA Healthcare, Inc. insiders were filed in the last 90 days; 1,343 institutions reported holding it in 13F filings for Q2 2026, worth $52.5B in total; superinvestors Harris Associates (Oakmark) and Markel Group hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by HCA Healthcare, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for HCA Healthcare, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. | 0Indirect | Aug 28, 2026 | 5 |
| Marks Mike A | EVP and CFO | 46,576Indirect | May 11, 2026 | 4 |
| Chidsey John | Director | 1,305 | Apr 30, 2026 | 1 |
| Deparle Nancy Ann | Director | 21,910 | Apr 30, 2026 | 1 |
| Michelson Michael W | Director | 12,576 | Apr 30, 2026 | 1 |
| Frist Thomas F III | Director, 10% Owner | 15,858 | Apr 30, 2026 | 2 |
| Johnston Hugh F | Director | 4,475 | Apr 30, 2026 | 1 |
| Riley Wayne Joseph | Director | 15,029 | Apr 30, 2026 | 1 |
| Frist William R | Director, 10% Owner | 13,740 | Apr 30, 2026 | 2 |
| Smith Andrea B | Director | 4,666 | Apr 30, 2026 | 1 |
| Hazen Samuel N | CEO | 64,842 | Feb 12, 2026 | 5 |
| Foster Jon M | EVP and COO | 23,062 | Feb 12, 2026 | 3 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 32,080 | Feb 12, 2026 | 3 |
| Wyatt Christopher F. | SVP & Controller | 44,379 | Feb 12, 2026 | 3 |
| Berres Jennifer | SVP & Chief Human Res. Officer | 11,993 | Feb 12, 2026 | 2 |
| Rossitto Erica | SVP & Chief Nurse Executive | 10,407 | Feb 12, 2026 | 1 |
| Frist Thomas F Jr | 10% Owner | 36,557,141Indirect | Feb 10, 2026 | 1 |
| Hercules Holding II | 10% Owner | 32,282,889 | Feb 10, 2026 | 1 |
| Frisco Holding II | 10% Owner | 36,557,141 | Feb 10, 2026 | 1 |
| Elcan Patricia F | 10% Owner | 36,557,141Indirect | Feb 10, 2026 | 1 |
| Dennis Robert J | Director | 26,601 | May 1, 2025 | 0 |
| Bank Of America Corp | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Merrill Lynch, Pierce, Fenner & Smith Inc. | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Bank Of America NA | 10% Owner | 0Indirect | Mar 28, 2025 | 0 |
| Mosier Sammie S | SVP & Chief Nurse Executive | 11,113 | Feb 18, 2025 | 0 |
| Whalen Kathleen M | SVP & Chief Ethics Officer | 9,454 | Nov 18, 2024 | 0 |
| Billington Phillip G | SVP-Internal Audit Services | 52,702 | Nov 14, 2024 | 0 |
| Akdamar Erol R | Group President | 6,843 | Nov 14, 2024 | 0 |
| Sowell Joseph A III | SVP; Chief Development Officer | 18,526Indirect | Aug 7, 2024 | 0 |
| McManus Timothy M | Group President | 27,008 | Aug 2, 2024 | 0 |
| Reiner Deborah M | SVP - Mktg. & Communications | 3,510 | Jul 31, 2024 | 0 |
| Torres Kathryn A. | SVP-Payer Contracting & Align. | 17,755 | Jul 29, 2024 | 0 |
| Cohen Jeffrey E. | SVP-Government Relations | 5,185 | May 13, 2024 | 0 |
| Crofton Meg | Director | 6,331 | May 1, 2024 | 0 |
| Wasserman Chad J | SVP and CIO | 1,576 | Mar 20, 2024 | 0 |
| Rutherford Bill B | CFO and EVP | 22,251 | Feb 21, 2024 | 0 |
| Hammett Richard A | Group President | 17,936 | Feb 21, 2024 | 0 |
| Paslick P. Martin | SVP and CIO | 24,643 | Apr 14, 2023 | 0 |
| Moore A Bruce Jr | Group President - Service Line | 30,807 | Nov 15, 2022 | 0 |
| Hall Charles J | Group President | 202,443 | Nov 15, 2022 | 0 |
| Holliday Charles O Jr | Director | 18,955 | Apr 27, 2022 | 0 |
| Englebright Jane D. | SVP and Chief Nursing Officer | 0 | Nov 12, 2021 | 0 |
| Perlin Jonathan B | Pres-Clinical Operations & CMO | 44,348Indirect | Aug 4, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 18 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −1.69K | $533.37 | −$903.5K | −16.1%8.85K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Wyatt Christopher F.SVP & Controller | SSale | −4.00K | $505.00 | −$2.02M | −8.3%44.4K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Berres JenniferSVP & Chief Human Res. Officer | SSale | −8.02K | $514.58 | −$4.13M | −40.1%12.0K after | 2 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Hazen Samuel NCEO | SSale | −42.9K | $501.04 | −$21.5M | −57.1%32.3K after | 7 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.50K | $498.09 | −$747.1K | −4.8%30.0K after | |
| Nov 5, 2025 (view filing) | Nov 5 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −3.89K | $473.79 | −$1.84M | −52.7%3.49K after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.84K | $418.84 | −$1.61M | −10.9%31.5K after | 10b5-1 |
| May 15, 2025 (view filing) | May 13 | 2 days | Foster Jon MEVP and COO | SSale | −15.7K | $369.32 | −$5.80M | −55.4%12.6K after | |
| Mar 28, 2025 (view filing)4:11 PM ET | Jul 26, 2011-Mar 19, 2012 | 4,994 daysLate | Bank Of America Corp and 2 others10% Owner | PPurchase | +3.44K | $25.67 | +$88.2K | New position0 after | 13 lots |
| Mar 28, 2025 (view filing)4:11 PM ET | Jan 10-Apr 3, 2012 | 4,826 daysLate | Bank Of America Corp and 2 others10% Owner | SSale | −3.18K | $25.12 | −$79.8K | −100.0%0 after | 17 lots |
| Feb 18, 2025 (view filing) | Feb 14 | 4 days | Berres JenniferSVP & Chief Human Res. Officer | SSale | −9.53K | $322.59 | −$3.08M | −38.2%15.4K after | 2 lots |
| Nov 18, 2024 (view filing) | Nov 14 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −1.47K | $357.99 | −$527.7K | −13.5%9.45K after | |
| Nov 14, 2024 (view filing) | Nov 14 | Same day | Billington Phillip GSVP-Internal Audit Services | SSale | −3.90K | $350.00 | −$1.36M | −6.9%52.7K after | |
| Nov 14, 2024 (view filing) | Nov 14 | Same day | Akdamar Erol RGroup President | SSale | −2.90K | $353.00 | −$1.02M | −29.8%6.84K after | |
| Sep 12, 2024 (view filing) | Sep 12 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −8.36K | $385.42 | −$3.22M | −22.0%29.7K after | 10b5-1 |
| Jul 31, 2024 (view filing) | Jul 29-31 | 2 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −4.85K | $362.13 | −$1.76M | −33.9%9.45K after | 2 lots |
| Jul 31, 2024 (view filing) | Jul 29 | 2 days | Reiner Deborah MSVP - Mktg. & Communications | SSale | −3.31K | $359.96 | −$1.19M | −48.6%3.51K after | |
| Jul 29, 2024 (view filing) | Jul 29 | Same day | Wyatt Christopher F.SVP & Controller | SSale | −4.00K | $360.20 | −$1.44M | −9.0%40.4K after | |
| Jul 29, 2024 (view filing) | Jul 25 | 4 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −1.86K | $355.05 | −$659.3K | −9.5%17.8K after | |
| May 20, 2024 (view filing) | May 16 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −3.20K | $326.30 | −$1.05M | −25.3%9.45K after | |
| May 17, 2024 (view filing) | May 15 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −1.86K | $326.18 | −$607.7K | −8.7%19.6K after | |
| May 13, 2024 (view filing) | May 9 | 4 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −6.31K | $316.88 | −$2.00M | −17.6%29.6K after | |
| May 13, 2024 (view filing) | May 9 | 4 days | Cohen Jeffrey E.SVP-Government Relations | SSale | −1.65K | $313.00 | −$516.5K | −24.1%5.18K after | |
| May 8, 2024 (view filing) | May 6 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.60K | $309.00 | −$494.4K | −4.5%34.1K after | |
| May 6, 2024 (view filing) | May 2-3 | 4 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −1.86K | $312.00 | −$581.3K | −8.0%21.5K after | 2 lots |
| Mar 20, 2024 (view filing) | Mar 18-20 | 2 days | Wasserman Chad JSVP and CIO | SSale | −1.22K | $327.92 | −$400.1K | −43.6%1.58K after | 2 lots10b5-1 |
| Feb 13, 2024 (view filing) | Feb 9 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −4.26K | $306.21 | −$1.31M | −29.4%10.3K after | |
| Feb 7, 2024 (view filing) | Feb 5 | 2 days | Wyatt Christopher F.SVP & Controller | SSale | −4.00K | $312.42 | −$1.25M | −9.7%37.4K after | |
| Feb 6, 2024 (view filing) | Feb 6 | Same day | Rutherford Bill BCFO and EVP | SSale | −6.00K | $310.63 | −$1.86M | −41.5%8.45K after | |
| Feb 6, 2024 (view filing) | Feb 5 | 1 day | Mosier Sammie SSVP & Chief Nurse Executive | SSale | −1.65K | $312.00 | −$513.2K | −17.7%7.65K after | |
| Feb 6, 2024 (view filing) | Feb 2 | 4 days | Wasserman Chad JSVP and CIO | SSale | −652 | $312.04 | −$203.5K | −69.2%290.31 after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −3.86K | $307.00 | −$1.19M | −19.5%15.9K after | |
| Feb 2, 2024 (view filing) | Jan 31 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.20K | $306.79 | −$981.7K | −11.4%24.9K after | |
| Aug 16, 2023 (view filing) | Aug 14 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −5.20K | $269.12 | −$1.40M | −20.8%19.8K after | |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | Cohen Jeffrey E.SVP-Government Relations | SSale | −1.50K | $270.00 | −$405.0K | −25.4%4.41K after | |
| Aug 7, 2023 (view filing) | Aug 3 | 4 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −2.92K | $270.00 | −$787.3K | −22.1%10.3K after | |
| May 2, 2023 (view filing) | Apr 28 | 4 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −12.6K | $284.44 | −$3.57M | −30.4%28.8K after | |
| May 2, 2023 (view filing) | Apr 28 | 4 days | Akdamar Erol RGroup President | SSale | −3.50K | $285.00 | −$997.5K | −7.6%42.5K after | |
| Apr 26, 2023 (view filing) | Apr 24 | 2 days | Torres Kathryn A.SVP-Payer Contracting & Align. | SSale | −4.47K | $288.38 | −$1.29M | −16.7%22.2K after | |
| Apr 14, 2023 (view filing) | Apr 14 | Same day | Paslick P. MartinSVP and CIO | SSale | −2.69K | $275.00 | −$738.9K | −9.8%24.6K after | |
| Apr 12, 2023 (view filing) | Apr 10 | 2 days | Paslick P. MartinSVP and CIO | SSale | −2.54K | $270.00 | −$685.5K | −9.3%24.6K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Paslick P. MartinSVP and CIO | SSale | −3.03K | $265.00 | −$804.0K | −11.0%24.6K after | |
| Feb 22, 2023 (view filing) | Feb 17 | 5 days | Whalen Kathleen MSVP & Chief Ethics Officer | SSale | −1.73K | $263.61 | −$457.1K | −14.8%9.96K after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Berres JenniferSVP & Chief Human Res. Officer | SSale | −4.00K | $255.23 | −$1.02M | −35.1%7.39K after | |
| Feb 7, 2023 (view filing) | Feb 3 | 4 days | Reiner Deborah MSVP - Mktg. & Communications | SSale | −7.94K | $257.61 | −$2.05M | −100.0%0 after | |
| Feb 6, 2023 (view filing) | Feb 2 | 4 days | Akdamar Erol RGroup President | SSale | −3.00K | $258.63 | −$775.9K | −8.0%34.7K after | |
| Feb 3, 2023 (view filing) | Feb 3 | Same day | Rutherford Bill BCFO and EVP | SSale | −30.0K | $258.19 | −$7.75M | −26.9%81.6K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Wyatt Christopher F.SVP & Controller | SSale | −4.90K | $253.30 | −$1.24M | −13.1%32.4K after | |
| Feb 1, 2023 (view filing) | Feb 1 | Same day | Paslick P. MartinSVP and CIO | SSale | −1.00K | $256.95 | −$256.9K | −25.0%3.00K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | McManus Timothy MGroup President | SSale | −7.90K | $254.06 | −$2.01M | −36.1%14.0K after | 2 lots |